Hereditary Breast and Ovarian Cancer



This activity is designed for cancer care providers, primary care physicians, gynecologists, and genetic counselors and will feature clinical cases highlighting the latest advances in the use of germline genetics for the care of cancer patients and their family members who are at increased cancer risk. The session will review emerging understanding of the role of DNA repair and cancer risk and opportunities to improve public health with genomic risk stratification. The case presentations and panel discussions will review new genetic tests and their clinical utility from panels of cancer genes to polygenic risk scores to predict risk of cancer. The organizers will review the pitfalls of variants of uncertain significance, what resources are available to assist with testing and interpretation, new guidelines for hereditary cancer management.

5.25 AMA PRA Category 1 Credits™ - maximum


May 5, 2022


Virtual Conference